Ultragenyx Pharmaceutical (RARE) Capital Expenditures (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,712.90% |
| Dec 31, 2025 | -104.85% |
| Sep 30, 2025 | -54.09% |
| Jun 30, 2025 | 178.40% |
| Mar 31, 2025 | 513.50% |
| Dec 31, 2024 | -97.25% |
| Sep 30, 2024 | 1,658.53% |
| Jun 30, 2024 | -129.77% |
| Mar 31, 2024 | 103.92% |
| Dec 31, 2023 | -189.24% |
| Sep 30, 2023 | 1,290.76% |
| Jun 30, 2023 | -133.64% |
| Mar 31, 2023 | 469.62% |
| Dec 31, 2022 | 4.33% |
| Sep 30, 2022 | -46.57% |
| Jun 30, 2022 | -107.11% |
| Mar 31, 2022 | 54.42% |
| Dec 31, 2021 | -21.95% |
| Sep 30, 2021 | 2.44% |
| Jun 30, 2021 | 22.28% |
| Mar 31, 2021 | -25.21% |
| Dec 31, 2020 | 480.58% |
| Sep 30, 2020 | -7.42% |
| Jun 30, 2020 | -71.03% |
| Mar 31, 2020 | 22.57% |
| Dec 31, 2019 | 128.49% |
| Sep 30, 2019 | -3.95% |
| Jun 30, 2019 | 71.30% |
| Mar 31, 2019 | 156.63% |
| Dec 31, 2018 | 15.50% |
| Sep 30, 2018 | -25.05% |
| Jun 30, 2018 | 189.89% |
| Mar 31, 2018 | 131.79% |
| Dec 31, 2017 | -244.63% |
| Sep 30, 2017 | 174.73% |
| Jun 30, 2017 | -22.47% |
| Mar 31, 2017 | 105.17% |
| Dec 31, 2016 | -412.40% |
| Sep 30, 2016 | -40.50% |
| Jun 30, 2016 | 241.50% |
| Mar 31, 2016 | -23.19% |
| Dec 31, 2015 | -2.78% |
| Sep 30, 2015 | 232.44% |
| Jun 30, 2015 | 29.63% |
| Mar 31, 2015 | 131.59% |
| Dec 31, 2014 | -196.67% |
| Sep 30, 2014 | 499.73% |
| Jun 30, 2014 | -166.08% |
| Mar 31, 2014 | 341.09% |
| Dec 31, 2013 | -36.45% |
| Sep 30, 2013 | 299.02% |
| Jun 30, 2013 | -157.63% |